Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YPEL1 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | NKIRAS1 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | SCN3A | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
mRNA | ACAA2 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | KCNH3 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
mRNA | STAU2 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | RP11-463C8.4 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | ZNF181 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | OVOS2 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
mRNA | RIMKLA | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |